16-74727290-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_024306.5(FA2H):c.460C>T(p.Arg154Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
FA2H
NM_024306.5 missense
NM_024306.5 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 6.03
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.895
PP5
Variant 16-74727290-G-A is Pathogenic according to our data. Variant chr16-74727290-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 30872.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=3, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FA2H | NM_024306.5 | c.460C>T | p.Arg154Cys | missense_variant | 3/7 | ENST00000219368.8 | NP_077282.3 | |
FA2H | XM_011523317.4 | c.460C>T | p.Arg154Cys | missense_variant | 3/6 | XP_011521619.1 | ||
FA2H | XM_011523319.3 | c.220C>T | p.Arg74Cys | missense_variant | 3/7 | XP_011521621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FA2H | ENST00000219368.8 | c.460C>T | p.Arg154Cys | missense_variant | 3/7 | 1 | NM_024306.5 | ENSP00000219368 | P1 | |
FA2H | ENST00000569949.1 | c.262C>T | p.Arg88Cys | missense_variant | 3/5 | 4 | ENSP00000464576 | |||
FA2H | ENST00000567683.5 | c.364-8130C>T | intron_variant, NMD_transcript_variant | 2 | ENSP00000455126 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251280Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135842
GnomAD3 exomes
AF:
AC:
6
AN:
251280
Hom.:
AF XY:
AC XY:
1
AN XY:
135842
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461848Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727222
GnomAD4 exome
AF:
AC:
14
AN:
1461848
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74342
GnomAD4 genome
AF:
AC:
1
AN:
152172
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 35 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 27, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 154 of the FA2H protein (p.Arg154Cys). This variant is present in population databases (rs387907040, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of FA2H-related conditions (PMID: 20853438, 27217339, 31135052, 32907636). ClinVar contains an entry for this variant (Variation ID: 30872). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FA2H protein function. Studies have shown that this missense change alters FA2H gene expression (PMID: 20853438). For these reasons, this variant has been classified as Pathogenic. - |
Neurodegeneration with brain iron accumulation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2023 | Variant summary: FA2H c.460C>T (p.Arg154Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251280 control chromosomes. c.460C>T has been reported in the literature in multiple individuals affected with FA2H-related conditions (e.g., Kruer_2010, Rattay_2019, Tsang_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence demonstrating reduced levels of protein expression in mutant cells, indicating reduced stability of the mRNA or protein product (Kruer_2010). The following publications have been ascertained in the context of this evaluation (PMID: 20853438, 31135052, 32907636). Three ClinVar submitters have submitted clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as a variant on uncertain significance, while two submitter classified it as likely pathogenic/pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 17, 2022 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29376581, 34758253, 24299421, 20853438, 29423566, 25141825, 31589614, 32907636, 34852264, 31837835, 27217339, 31135052) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Pathogenic
D;.
Polyphen
D;.
Vest4
MutPred
Gain of catalytic residue at L155 (P = 0.0135);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at